[登录] [免费注册]
试剂仪器网
位置:首页 > 资料中心 > 化工字典 > 84057-84-1
关键词:       仅模糊查询
CAS: 84057-84-1
分子式: C9H7Cl2N5
分子量: 256.09
中文名称: 
拉莫三嗪
英文名称: 
lamictal
lamotrigine
4-triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-2
3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
bw 430c
用途: 顽固性癫痫药。
推荐供应商
货号品牌产品名称规格包装、参考价格
L795918MACKLIN拉莫三嗪10mM in DMSO467元/1ml;   咨询
储存:-20°C
L0241TCILamotrigine>98.0%(T)(HPLC)150元/1G;   550元/5G;   咨询

基本信息

纯度/分析方法>98.0%(T)(HPLC)
分子式/分子量C9H7Cl2N5 = 256.09
外观与形状(20℃)固体
储存温度0-10℃
储存在惰性气体下存放于惰性气体之中
应避免的情况空气,加热
Reaxys-RN7589268
PubChem物质ID160871245
Merck Index (14)5353
MDL编号MFCD00865333

技术规格

AppearanceWhite to Almost white powder to crystal
Purity(HPLC)min. 98.0 area%
Purity(Nonaqueous Titration)min. 98.0 %
Melting point216.0 to 220.0 ℃

物性(参考值)

熔点218 ℃
溶解性(可溶于)二甲基甲酰胺

安全信息

图形或危害标志
信号词危险
危险性说明H301 : 吞咽会中毒。
防范说明P501 : 将内装物/容器送到批准的废物处理厂处理。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。

相关法规

RTECS#XY5850700

运输信息

UN编号UN2811
类别6.1
包装类别 III
监管条件代码(*)
185928J&KLamotrigine98%, 一种新型抗惊厥药剂, 可抑制5-羟色胺(5-HT)吸收656元/1G;   2233元/5G;   咨询

基本信息

分子式C9H7Cl2N5
分子量256.09
熔点216-220
MDL编码MFCD00865333
Beilstein7589268
Merck14,5353
EINECS 编号281-901-8
存储条件Freezer -20℃

产品描述

Lamotrigine是一种新型抗惊厥药剂,作用于人类血小板和大鼠脑突触体,抑制5-羟色胺(5-HT)吸收,IC50分别为240 μM和474 μM。

靶点(IC50 & Targe)

5-HT (human platelets),240μM

5-HT (rat brain synaptosomes),474μM

体外研究

Lamotrigine通过阻断电压依赖性钠通道稳定突触前神经元膜,从而防止兴奋性神经递质,尤其是谷氨酸和天冬氨酸的释放。[1]用10毫克/升藜芦碱培育的大鼠大脑皮层组织,lamotrigine抑制谷氨酸和天冬氨酸(两者ED 50 = 5.38 毫克/升)的释放比抑制GABA (ED50 = 11.2 毫克/升)的释放有效两倍,并且当皮层切片暴露在75毫克/升藜芦碱时,lamotrigine抑制乙酰胆碱的释放(ED50 = 25.6 毫克/升)效力降低很多。基础谷氨酸的释放不受影响。[2] Lamotrigine抑制钠依赖性动作电位的高频率持续节律放电,表明对电压激活的钠离子通道具有直接作用。[3] Lamotrigine不会诱导PCP样中枢神经系统(CNS)效应,不会通过直接抑制NMDA受体发挥作用,并可能导致与NMDA阻断相关的不良效应缺乏。[4]

体内研究

在小鼠和大鼠体内,lamotrigine防止MES和戊四氮诱导的后肢伸展,表明在动物中具有抗癫痫作用。lamotrigine给药后1小时这些作用达到最大值,并且能够持续超过24小时。[4] Lamotrigine在电诱发的EEG后放电测试中是活跃的,这表明其能够抵抗简单和复杂的部分性发作。大鼠体内lamotrigine以>5 毫克/千克的剂量静脉内给药,后放电持续时间剂量依赖性减少。[5]

动物实验

Animal Models: 狗/大鼠

Formulation: 悬浮在0.25%甲基纤维素溶液中

Dosages: 狗和大鼠体内分别为4.5和11.7毫克/千克

Administration: 静脉注射

(Only for Reference)

参考文献

[1] Goa KL, et al. Drugs, 1993, 46(1), 152-176.

[2] Leach MJ, et al. Epilepsia, 1986, 27(5), 490-497.

[3] Cheung H, et al. Epilepsy Res, 1992, 13(2), 107-112.

[4] Miller AA, et al. Epilepsia, 1986, 27(5), 483-489.

[5] Wheatley PL, et al. Epilepsia, 1989, 30(1), 34-40.

[6] Lamotrigine

安全信息

图形或危害标志
提示语Danger
危险说明H301
防范说明P301+P310
UN号码2811
危险分类6.1
包装等级III
WGK3
RTECSXY5850700
C46085Alfa AesarLamotrigine98%1001元/1g;   3496元/5g;   咨询

基本信息

Ref#
46085

分子式
C9H7Cl2N5

分子量
358.50

GHS危害和防范说明

GHS符号

Hazard Statements
H301
Toxic if swallowed.

Precautionary Statements
P264 P301+P310

安全信息

危险等级
6.1

PHR1392SupelcoLamotriginePharmaceutical Secondary Standard; Certified Reference Material1479.89元/1 G;   咨询

产品说明

一般描述

Lamotrigine is an anticonvulsant drug, which is widely used in the treatment of epilepsy and bipolar disorders. It is also used in combination with other antiepileptics to treat refractory partial seizures, generalized tonic-clonic seizures and generalized toxic-chronic seizures.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

应用

These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Labetalol Hydrochloride may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using spectrophotometric technique.

生化/生理作用

抗惊厥剂。

分析说明

These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available.

其他说明

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

附注

To see an example of a Certificate of Analysis for this material enter LRAC3640 in the slot below. This is an example certificate only and may not be the lot that you receive.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
EC 号281-901-8
MDL编号MFCD00865333
PubChem化学物质编号329823366
NACRESNA.24

产品性质

质量水平300
等级certified reference material
pharmaceutical secondary standard
CofAcurrent certificate can be downloaded
technique(s)HPLC: suitable
gas chromatography (GC): suitable
application(s)pharmaceutical (small molecule)
格式neat
药典可追溯性traceable to PhEur Y0001030
traceable to USP 1356756
储存温度2-30℃
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0001030LamotrigineEuropean Pharmacopoeia (EP) Reference Standard1572.27元/ ;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

抗惊厥剂。

包装

Unit quantity: 15 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
MDL编号MFCD00865333
PubChem化学物质编号329831227
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0001031Lamotrigine for peak identificationEuropean Pharmacopoeia (EP) Reference Standard1861.35元/ ;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

抗惊厥剂。

包装

Unit quantity: 20 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
MDL编号MFCD00865333
PubChem化学物质编号329831228
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
储存温度2-8℃
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
Y0001085Lamotrigine for system suitabilityEuropean Pharmacopoeia (EP) Reference Standard1259.15元/ ;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

抗惊厥剂。

包装

Unit quantity: 10 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

注意

Please find SDS provided by EDQM here..

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
MDL编号MFCD00865333
PubChem化学物质编号329831255
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameEDQM
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
L3791Sigma-AldrichLamotrigine≥98%, powder1956.53元/10 MG;   8084.99元/50 MG;   咨询

产品说明

包装

10, 50 mg in glass bottle

生化/生理作用

抗惊厥剂。

特点和优势

该化合物由 GlaxoSmithKline 开发。想要浏览其他由制药公司开发的化合物以及已批准药物/候选药物清单,请单击此处。

其他说明

斯克里普斯代谢组学和质谱技术中心独立生成的串联质谱数据可在PDFL3791.pdf 中查看或下载。斯克里普斯代谢物组学和质谱技术中心的METLIN代谢物数据库中有测试代谢物。要了解更多信息,请访问sigma.com/metlin。

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
EC 号281-901-8
MDL编号MFCD00865333
PubChem化学物质编号24278792
NACRESNA.77

产品性质

质量水平200
测定≥98%
形式powder
颜色 white
溶解性DMSO: soluble 20 mg/mL at 60 ℃
H2O: insoluble
创始人GlaxoSmithKline
储存温度2-8℃
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)
rat ... Scn2a1(24766), Scnn1a(25122)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
个人防护装备Eyeshields, Faceshields, Gloves, type P2 (EN 143) respirator cartridges
1356756USPLamotrigineUnited States Pharmacopeia (USP) Reference Standard12133.8元/150 MG;   咨询

产品说明

生化/生理作用

抗惊厥剂。

分析说明

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他说明

USP issued SDS can be found here.
Sales restrictions may apply.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
MDL编号MFCD00865333
PubChem化学物质编号329750224
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameUSP
application(s)pharmaceutical (small molecule)
格式neat
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
BP1097LamotrigineBritish Pharmacopoeia (BP) Reference Standard1861.35元/200 MG;   咨询

产品说明

一般描述

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

生化/生理作用

抗惊厥剂。

包装

Unit quantity: 200 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他说明

Sales restrictions may apply.

基本信息

经验(实验)分子式C9H7Cl2N5
分子量256.09
EC 号281-901-8
MDL编号MFCD00865333
NACRESNA.24

产品性质

等级pharmaceutical primary standard
manufacturer/tradenameBP
格式neat
储存温度2-8℃
SMILES stringNc1nnc(c(N)n1)-c2cccc(Cl)c2Cl
InChI1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)
InChI keyPYZRQGJRPPTADH-UHFFFAOYSA-N
Gene Informationhuman ... SCN10A(6336), SCN11A(11280), SCN1A(6323), SCN2A(6326), SCN3A(6328), SCN4A(6329), SCN5A(6331), SCN7A(6332), SCN8A(6334), SCN9A(6335)

安全信息

象形图GHS06
警示用语:Danger
危险声明H301
预防措施声明P264 - P270 - P301 + P310 - P405 - P501
危险分类Acute Tox. 3 Oral
储存分类代码6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
WGKWGK 3
闪点(F)Not applicable
闪点(C)Not applicable
093440Fluorochem6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine95%1188元/1g;   4268元/5g;   咨询

基本信息

CAS Number84057-84-1
MDL NumberMFCD00865333
Boiling Point503.1℃
Melting Point218℃
Density1.572

安全信息

图形或危害标志
危险性说明 EUH401: To avoid risks to human health and the environment, comply with the instructions for use.
H301: Toxic if swallowed.
H315: Causes skin irritation.
H319: Causes serious eye irritation.
H332: Harmful if inhaled.
H335: May cause respiratory irritation.
防范说明 P233: Keep container tightly closed.
P260: Do not breathe .
P261: Avoid breathing .
P264: Wash hands thoroughly after handling.
P270: Do not eat, drink or smoke when using this product.
P271: Use only outdoors or in a well-ventilated area.
P280: Wear .
P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician.
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P304: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing..
P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312: Call a POISON CENTER or doctor/physician if you feel unwell.
P321: Specific treatment (see relevant procedures. on this label).
P330: Rinse mouth.
P332 + P313: If skin irritation occurs: Get medical advice/ attention.
P337 + P313: If eye irritation persists: Get medical advice/attention.
P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P362: Take off contaminated clothing and wash before reuse.
P403: Store in a well-ventilated place.
P403 + P233: Store in a well-ventilated place. Keep container tightly closed.
P405: Store locked up.
P501: Dispose of contents/container to in accordance with local regulation .
CAS号首数字顺序排列: 1 2 3 4 5 6 7 8 9